Showing results (331-340 of 439) with videos related to

Sort By:
Pageof 44
British Journal of Haematology|July 5, 2012
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phaseDisni Muringampurath-John, David L Jaye, Christopher R Flowers, et al.
Blood Advances|July 24, 2026
Clinical utility of real-time comprehensive molecular testing in large B-cell lymphomaDai Chihara, Kumudha Balakrishnan, Gita Masand, et al.
Cancer Discovery|April 20, 2022
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell LymphomagenesisWilfred Leung, Matt Teater, Ceyda Durmaz, et al.
Cancer|March 27, 2018
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapyI Brian Greenwell, Ashley D Staton, Michael J Lee, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJames R Cerhan, Anne Kricker, Ora Paltiel, et al.
Blood|January 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicityChristopher Ronald Funk, Shuhua Wang, Kevin Z Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2025
PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapyAndres Chang, Adam N Pelletier, Donald J McGuire, et al.
Leukemia & Lymphoma|November 3, 2025
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort studyNadia Toumeh, Melissa Larson, Brianna Negaard, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphomaEhsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First RemissionGordon Glober, Jillian Gunther, Penny Fang, et al.
Pageof 44